A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-lundberg, W. H. Ho et al., Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron, vol.25, pp.80886-80893, 2000.

J. Aharon-peretz, H. Rosenbaum, and R. Gershoni-baruch, Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews, N. Engl. J. Med, vol.351, pp.1972-1977, 2004.

L. Alvarez-erviti, M. C. Rodriguez-oroz, J. M. Cooper, C. Caballero, I. Ferrer et al., Chaperone-mediated autophagy markers in Parkinson disease brains, Arch. Neurol, vol.67, pp.1464-1472, 2010.

L. Alvarez-erviti, Y. Seow, A. H. Schapira, C. Gardiner, I. L. Sargent et al., Lysosomal dysfunction increases exosome-mediated alphasynuclein release and transmission, Neurobiol. Dis, vol.42, pp.360-367, 2011.

J. P. Anderson, D. E. Walker, J. M. Goldstein, R. De-laat, K. Banducci et al., Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease, J. Biol. Chem, vol.281, pp.29739-29752, 2006.

S. Appel-cresswell, C. Vilarino-guell, M. Encarnacion, H. Sherman, I. Yu et al., Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease, Mov. Disord, vol.28, pp.811-813, 2013.

A. Athanassiadou, G. Voutsinas, L. Psiouri, E. Leroy, M. H. Polymeropoulos et al., Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein, Am. J. Hum. Genet, vol.65, pp.555-558, 1999.

P. K. Auluck, G. Caraveo, and S. Lindquist, alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease, Annu. Rev. Cell Dev. Biol, vol.26, pp.211-233, 2010.

T. Bartels, J. G. Choi, and D. J. Selkoe, alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, vol.477, pp.107-110, 2011.

S. Bellani, V. L. Sousa, G. Ronzitti, F. Valtorta, J. Meldolesi et al., The regulation of synaptic function by alpha-synuclein, Commun. Integr. Biol, vol.3, pp.106-109, 2010.

A. Bender, K. J. Krishnan, C. M. Morris, G. A. Taylor, A. K. Reeve et al., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease, Nat. Genet, vol.38, pp.515-517, 2006.

J. Bové, M. Martinez-vicente, B. Dehay, C. Perier, A. Recasens et al., BAX channel activity mediates lysosomal disruption linked to Parkinson disease, Autophagy, vol.10, pp.889-900, 2014.

P. Boya and G. Kroemer, Lysosomal membrane permeabilization in cell death, Oncogene, vol.27, pp.6434-6451, 2008.

P. Boya, F. Reggiori, and P. Codogno, Emerging regulation and functions of autophagy, Nat. Cell Biol, vol.15, pp.713-720, 2013.

J. Bras, R. Guerreiro, L. Darwent, L. Parkkinen, O. Ansorge et al., Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies, Hum. Mol. Genet, 2014.

M. C. Chartier-harlin, J. Kachergus, C. Roumier, V. Mouroux, X. Douay et al., Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet, vol.364, pp.17103-17104, 2004.

J. M. Choi, M. S. Woo, H. I. Ma, S. Y. Kang, Y. H. Sung et al., Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease, Neurogenetics, vol.9, pp.263-269, 2008.

Y. Chu, H. Dodiya, P. Aebischer, C. W. Olanow, and J. H. Kordower, Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions, Neurobiol. Dis, vol.35, pp.385-398, 2009.

A. A. Cooper, A. D. Gitler, A. Cashikar, C. M. Haynes, K. J. Hill et al., Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models, Science, vol.313, pp.324-328, 2006.

O. Corti, S. Lesage, and A. Brice, What genetics tells us about the causes and mechanisms of Parkinson's disease, Physiol. Rev, vol.91, pp.1161-1218, 2011.

N. Cremades, S. I. Cohen, E. Deas, A. Y. Abramov, A. Y. Chen et al., Direct observation of the interconversion of normal and toxic forms of alpha-synuclein, Cell, vol.149, pp.1048-1059, 2012.

R. A. Crowther, S. E. Daniel, and M. Goedert, Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain, Neurosci. Lett, vol.292, pp.128-130, 2000.

A. M. Cuervo, Autophagy's top chef, Science, vol.332, pp.1392-1393, 2011.

A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer, Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy, Science, vol.305, pp.1292-1295, 2004.

M. Decressac, B. Mattsson, P. Weikop, M. Lundblad, J. Jakobsson et al., TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity, Proc. Natl. Acad. Sci. U S A, vol.110, pp.1817-1826, 2013.

C. De-duve, B. C. Pressman, R. Gianetto, R. Wattiaux, and F. Appelmans, Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochem. J, vol.60, pp.604-617, 1955.

B. Dehay, J. Bové, N. Rodriguez-muela, C. Perier, A. Recasens et al., Pathogenic lysosomal depletion in Parkinson's disease, J. Neurosci, vol.30, pp.12535-12544, 2010.

B. Dehay, A. Ramirez, M. Martinez-vicente, C. Perier, M. H. Canron et al., Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proc. Natl. Acad. Sci. U S A, vol.109, pp.9611-9616, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01290058

A. Di-fonzo, H. F. Chien, M. Socal, S. Giraudo, C. Tassorelli et al., ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, vol.68, pp.1557-1562, 2007.

V. Dorval and P. E. Fraser, Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein, J. Biol. Chem, vol.281, pp.9919-9924, 2006.

E. Dufour and N. G. Larsson, Understanding aging: revealing order out of chaos, Biochim. Biophys. Acta, vol.1658, pp.122-132, 2004.

T. L. Edwards, W. K. Scott, C. Almonte, A. Burt, E. H. Powell et al., Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease, Ann. Hum. Genet, vol.74, pp.97-109, 2010.

E. Emmanouilidou, K. Melachroinou, T. Roumeliotis, S. D. Garbis, M. Ntzouni et al., Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival, J. Neurosci, vol.30, pp.6838-6851, 2010.

E. L. Eskelinen, Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death, Cell Death Differ, vol.12, pp.1468-1472, 2005.

M. Filimonenko, P. Isakson, K. D. Finley, M. Anderson, H. Jeong et al., The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy, Mol. Cell, vol.38, pp.265-279, 2010.

D. Freeman, R. Cedillos, S. Choyke, Z. Lukic, K. Mcguire et al., Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis, PLoS One, vol.8, p.62143, 2013.

H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah et al., alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat. Cell Biol, vol.4, pp.160-164, 2002.

B. I. Giasson, J. E. Duda, I. V. Murray, Q. Chen, J. M. Souza et al., Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions, Science, vol.290, pp.985-989, 2000.

A. D. Gitler, B. J. Bevis, J. Shorter, K. E. Strathearn, S. Hamamichi et al., The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis, Proc. Natl. Acad. Sci. U S A, vol.105, pp.145-150, 2008.

M. Goedert, M. G. Spillantini, K. Del-tredici, and H. Braak, 100 years of Lewy pathology, Nat. Rev. Neurol, vol.9, pp.13-24, 2013.

O. Goker-alpan, B. K. Stubblefield, B. I. Giasson, and E. Sidransky, Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders, Acta Neuropathol, vol.120, pp.641-649, 2010.

C. Guardia-laguarta, E. Area-gomez, C. Rüb, Y. Liu, J. Magrane et al., alpha-Synuclein is localized to mitochondria-associated ER membranes, J. Neurosci, vol.34, pp.249-259, 2014.

C. Hansen, E. Angot, A. L. Bergstrom, J. A. Steiner, L. Pieri et al., alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J. Clin. Invest, vol.121, pp.715-725, 2011.

L. Y. Hao, B. I. Giasson, and N. M. Bonini, DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function, Proc. Natl. Acad. Sci. U S A, vol.107, pp.9747-9752, 2010.

C. International-parkinson-disease-genomics, M. A. Nalls, V. Plagnol, D. G. Hernandez, M. Sharma et al., Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies, Lancet, vol.377, issue.10, pp.62345-62353, 2011.

J. M. Jenco, A. Rawlingson, B. Daniels, and A. J. Morris, Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha-and beta-synucleins, Biochemistry, vol.37, pp.4901-4909, 1998.

T. Kabuta, R. Setsuie, T. Mitsui, A. Kinugawa, M. Sakurai et al., Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1, Hum. Mol. Genet, vol.17, pp.1482-1496, 2008.

K. Kågedal, A. C. Johansson, U. Johansson, G. Heimlich, K. Roberg et al., Lysosomal membrane permeabilization during apoptosisinvolvement of Bax?, Int. J. Exp. Pathol, vol.86, pp.309-321, 2005.

C. S. Ki, E. F. Stavrou, N. Davanos, W. Y. Lee, E. J. Chung et al., The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease, Clin. Genet, vol.71, pp.471-473, 2007.

R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber et al., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet, vol.18, pp.106-108, 1998.

P. Krumova, E. Meulmeester, M. Garrido, M. Tirard, H. H. Hsiao et al., Sumoylation inhibits alpha-synuclein aggregation and toxicity, J. Cell Biol, vol.194, pp.49-60, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02193319

H. A. Lashuel, C. R. Overk, A. Oueslati, and E. Masliah, The many faces of alpha-synuclein: from structure and toxicity to therapeutic target, Nat. Rev. Neurosci, vol.14, pp.38-48, 2013.

H. J. Lee, S. Patel, and S. J. Lee, Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J. Neurosci, vol.25, pp.6016-6024, 2005.

S. Lesage, M. Anheim, F. Letournel, L. Bousset, A. Honore et al., G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome, Ann. Neurol, vol.73, pp.459-471, 2013.

E. Lloyd-evans and F. M. Platt, Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases, Cell Calcium, vol.50, pp.200-205, 2011.

K. C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'brien et al., Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice, Science, vol.338, pp.949-953, 2012.

J. P. Luzio, P. R. Pryor, and N. A. Bright, Lysosomes: fusion and function, Nat. Rev. Mol. Cell Biol, vol.8, pp.622-632, 2007.

S. K. Mak, A. L. Mccormack, A. B. Manning-bog, A. M. Cuervo, D. Monte et al., Lysosomal degradation of alpha-synuclein in vivo, J. Biol. Chem, vol.285, pp.13621-13629, 2010.

C. Malagelada, Z. H. Jin, V. Jackson-lewis, S. Przedborski, and L. A. Greene, Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J. Neurosci, vol.30, pp.1166-1175, 2010.

L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland et al., Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death, J. Neurosci, vol.26, pp.41-50, 2006.

M. Martinez-vicente, Z. Talloczy, S. Kaushik, A. C. Massey, J. Mazzulli et al., Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy, J. Clin. Invest, vol.118, pp.777-788, 2008.

M. Martinez-vicente and M. Vila, Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop, Exp. Neurol, vol.247, pp.308-313, 2013.

M. P. Mattson, M. , and T. , Ageing and neuronal vulnerability, Nat. Rev. Neurosci, vol.7, pp.278-294, 2006.

J. R. Mazzulli, Y. H. Xu, Y. Sun, A. L. Knight, P. J. Mclean et al., Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, vol.146, pp.37-52, 2011.

G. Mercado, P. Valdés, and C. Hetz, An ERcentric view of Parkinson's disease, Trends Mol. Med, vol.19, pp.165-175, 2013.

K. Nakamura, V. M. Nemani, F. Azarbal, G. Skibinski, J. M. Levy et al., Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein, J. Biol. Chem, vol.286, pp.20710-20726, 2011.

E. H. Norris, B. I. Giasson, H. Ischiropoulos, and V. M. Lee, Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications, J. Biol. Chem, vol.278, pp.27230-27240, 2003.

S. J. Orenstein, S. H. Kuo, I. Tasset, E. Arias, H. Koga et al., Interplay of LRRK2 with chaperone-mediated autophagy, Nat. Neurosci, vol.16, pp.394-406, 2013.

P. Pasanen, L. Myllykangas, M. Siitonen, A. Raunio, S. Kaakkola et al., A novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology, Neurobiol. Aging, vol.35, 2014.

M. H. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997.

C. Proukakis, C. G. Dudzik, T. Brier, D. S. Mackay, J. M. Cooper et al., A novel alpha-synuclein missense mutation in Parkinson disease, Neurology, vol.80, pp.1062-1064, 2013.

A. Puschmann, O. A. Ross, C. Vilarino-guell, S. J. Lincoln, J. M. Kachergus et al., A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction, Parkinsonism Relat. Disord, vol.15, pp.627-632, 2009.

A. Ramirez, A. Heimbach, J. Gründemann, B. Stiller, D. Hampshire et al., Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat. Genet, vol.38, pp.1184-1191, 2006.

A. Recasens, B. Dehay, J. Bové, I. Carballo-carbajal, S. Dovero et al., Lewy body extracts from Parkinson disease brains trigger alphasynuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol, vol.75, pp.351-362, 2014.

A. Rodriguez, P. Webster, J. Ortego, and N. W. Andrews, Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells, J. Cell Biol, vol.137, pp.93-104, 1997.

R. Ruivo, C. Anne, C. Sagné, and B. Gasnier, Molecular and cellular basis of lysosomal transmembrane protein dysfunction, Biochim. Biophys. Acta, vol.1793, pp.636-649, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00415318

P. Saftig, B. Schröder, and J. Blanz, Lysosomal membrane proteins: life between acid and neutral conditions, Biochem. Soc. Trans, vol.38, pp.1420-1423, 2010.

A. H. Schapira, J. M. Cooper, D. Dexter, P. Jenner, J. B. Clark et al., Mitochondrial complex I deficiency in Parkinson's disease, Lancet, vol.1, p.1269, 1989.

B. Schröder, C. Wrocklage, C. Pan, R. Jäger, B. Kösters et al., Integral and associated lysosomal membrane proteins, Traffic, vol.8, pp.1676-1686, 2007.

C. Settembre, A. Fraldi, D. L. Medina, and A. Ballabio, Signals from the lysosome: a control centre for cellular clearance and energy metabolism, Nat. Rev. Mol. Cell Biol, vol.14, pp.283-296, 2013.

C. Settembre, R. Zoncu, D. L. Medina, F. Vetrini, S. Erdin et al., A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J, vol.31, pp.1095-1108, 2012.

E. Sidransky, M. A. Nalls, J. O. Aasly, J. Aharon-peretz, G. Annesi et al., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, N. Engl. J. Med, vol.361, pp.1651-1661, 2009.

J. Simón-sánchez, C. Schulte, J. M. Bras, M. Sharma, J. R. Gibbs et al., Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nat. Genet, vol.41, pp.1308-1312, 2009.

A. B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague et al., alpha-Synuclein locus triplication causes Parkinson's disease, Science, vol.302, p.841, 2003.

B. Spencer, R. Potkar, M. Trejo, E. Rockenstein, C. Patrick et al., Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases, J. Neurosci, vol.29, pp.13578-13588, 2009.

M. G. Spillantini and M. Goedert, The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, 2000.

, Ann. N Y Acad. Sci, vol.920, pp.16-27

M. G. Spillantini, M. L. Schmidt, V. M. Lee, J. Q. Trojanowski, R. Jakes et al., Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-840, 1997.

P. J. Spira, D. M. Sharpe, G. Halliday, J. Cavanagh, and G. A. Nicholson, Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation, Ann. Neurol, vol.49, pp.313-319, 2001.

A. N. Stefanovic, M. T. Stöckl, M. M. Claessens, and V. Subramaniam, alpha-Synuclein oligomers distinctively permeabilize complex model membranes, FEBS J, vol.281, pp.2838-2850, 2014.

A. Takeda, M. Mallory, M. Sundsmo, W. Honer, L. Hansen et al., Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders, Am. J. Pathol, vol.152, pp.367-372, 1998.

K. J. Thomas, M. K. Mccoy, J. Blackinton, A. Beilina, M. Van-der-brug et al., DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy, Hum. Mol. Genet, vol.20, pp.40-50, 2011.

G. K. Tofaris, A. Razzaq, B. Ghetti, K. S. Lilley, and M. G. Spillantini, Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function, J. Biol. Chem, vol.278, pp.44405-44411, 2003.

M. Vila, J. Bové, B. Dehay, N. Rodriguez-muela, and P. Boya, Lysosomal membrane permeabilization in Parkinson disease, Autophagy, vol.7, pp.98-100, 2011.

J. L. Webb, B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein, Alpha-Synuclein is degraded by both autophagy and the proteasome, J. Biol. Chem, vol.278, pp.25009-25013, 2003.

B. Winner, R. Jappelli, S. K. Maji, P. A. Desplats, L. Boyer et al., In vivo demonstration that alpha-synuclein oligomers are toxic, Proc. Natl. Acad. Sci. U S A, vol.108, pp.4194-4199, 2011.

E. Wong and A. M. Cuervo, Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci, vol.13, pp.805-811, 2010.

M. Xilouri, O. R. Brekk, N. Landeck, P. M. Pitychoutis, T. Papasilekas et al., Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration, Brain, vol.136, pp.2130-2146, 2013.

A. Yamamoto and A. Simonsen, The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration, Neurobiol. Dis, vol.43, pp.17-28, 2011.

G. Yamin, V. N. Uversky, and A. L. Fink, Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers, FEBS Lett, vol.542, pp.147-152, 2003.

Q. Yang, H. She, M. Gearing, E. Colla, M. Lee et al., Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy, Science, vol.323, pp.124-127, 2009.

J. J. Zarranz, J. Alegre, J. C. Gómez-esteban, E. Lezcano, R. Ros et al., The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol, vol.55, pp.164-173, 2004.